| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |